Suchergebnisse - "Madariaga, Ainhoa"

PubPharm (48)

1

Mirvetuximab soravtansine : an oasis in the desert?

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Bonilla, L. | Kasherman, L. | Manso, L. | +1

2

HER2-low and Overexpression in Mucinous Ovarian Cancer : Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring

enthalten in: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists | 2024

von Han, R. | Madariaga, A. | Gonzalez-Ochoa, E. | +4

3

High grade adverse event reporting and enrolment in gynecologic oncology clinical trials

enthalten in: Gynecologic oncology | 2024

von Madariaga, A. | Cole, H. | Pittman, T. | +7

4

New horizons for platinum-resistant ovarian cancer : insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) Annual Meetings

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von El Bairi, K. | Madariaga, A. | Trapani, D. | +2

5

Heterogeneity and treatment landscape of ovarian carcinoma

enthalten in: Nature reviews. Clinical oncology | 2023

von Veneziani, A. | Gonzalez-Ochoa, E. | Alqaisi, H. | +5

6

Digging into phenotype change in mismatch repair deficient endometrial carcinoma and treatment with immune checkpoint inhibition, a case report

enthalten in: Gynecologic oncology reports | 2023

von Rey-Cárdenas, M. | Parrilla-Rubio, L. | Manso, L. | +3

7

Side effects screening and early intervention to impact in quality of life of patients with gynecological cancers (HALIS study)

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Gil-Ibanez, B. | Tejerizo-Garcia, A. | Oliver, M. | +4

8

Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Terán, S. | Alva, M. | Tolosa, P. | +7

9

Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Lheureux, S. | Prokopec, S. | Oldfield, L. | +19

10

Safety of fertility sparing management in invasive mucinous ovarian carcinoma

enthalten in: Gynecologic oncology | 2023

von Kim, S. | Madariaga, A. | Hogen, L. | +5

1
2
3
4
5
Nächster »
[5]